Literature DB >> 2226599

Pros and cons of retroperitoneal lymphadenectomy in operable renal cell carcinoma.

G Pizzocaro1, L Piva.   

Abstract

Entities:  

Mesh:

Year:  1990        PMID: 2226599     DOI: 10.1159/000463953

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

Review 1.  The role of adjuvant immunotherapy in renal cell carcinoma.

Authors:  Peter F A Mulders; Pieter H M De Mulder
Journal:  Curr Urol Rep       Date:  2002-02       Impact factor: 2.862

2.  Reassessment of American Joint Committee on Cancer Staging for Stage III Renal Cell Carcinoma With Nodal Involvement: Propensity Score Matched Analyses of a Large Population-Based Study.

Authors:  Jianglong Han; Qin Li; Ping Li; Shijie Wang; Rui Zhang; Yunfeng Qiao; Qibin Song; Zhenming Fu
Journal:  Front Oncol       Date:  2020-03-19       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.